Clear Labs
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1559 Industrial Rd, San Carlos, Californ...Phone Number
(650) 257-3304Website
www.clearlabs.comRevenue
$10.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
3
1
1
About Clear Labs
Clear Labs, Inc. is a private genomics testing company headquartered in San Carlos, California, United States. It offers a fully automated, next-generation sequencing (NGS) platform for turnkey diagnostics, including SARS-CoV-2 genomic characterization and detection of foodborne pathogens such as listeria and salmonella. Clear Labs was co-founded by Sasan Amini in 2014, In December 2016, the company closed a $16 million Series B funding round. This was followed by another $21 million round in October 2018. Clear Labs was granted an Emergency Use Authorization (EUA) from the US FDA in September 2020 for its SARS-CoV-2 descriptive diagnostic test. Clear Labs has also received governmental and professional certification for its food safety next generation sequencing platform, including from the International AOACExplore more
Clear Labs Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Clear Labs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Clear Labs has recently received funding, and reach out quickly before it becomes old news!
Check out if Clear Labs is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Clear Labs launches new products
Earning: See what the market has to say on Clear Labs recently announced quarterly report
Click to see if Clear Labs had a recent Job posting/layoffs
Clear Labs, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Clear Labs
Funding: Get notified immidiatlly once Clear Labs has new funding data
Recommended Actions
Find VP level buyers at Clear Labs
Find 3 more new buyers
Compare Similar Companies to Clear Labs
Compare insights from companies similar to Clear Labs, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Clear Labs is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Clear Labs is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Clear Labs.
Clear Labs financials insights
Gather financial insights about Clear Labs, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$6.5M
2017
Private Equity
$16M
2020
Other Financing Round
$18M
2021
Series C
$60M
2025
Series D
$30M
Clear Labs Tech Stack
A closer look at the technologies used by Clear Labs
See more technologies
Most Recent Scoops
Funding
Funding
Event
will be attending the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo conference as an exhibitor. The event will occur from July 24 to July 28, 2022.
New Hire
Executive Move
Clear Labs has announced that Edward Fan has joined the organization as Chief Financial Officer. Previously, Fan served as Executive Director, Healthcare Investment Banking for J.P. Morgan.
Open Position
Funding
Clear Labs News & Media
Clear Labs Unveils Automated Workflow Featuring Pillar Biosciences' SLIMamp® Technology at AMP 2025
Clear Labs announced a new automated workflow featuring Pillar Biosciences' SLIMamp® chemistry on the Clear Dx™ platform, debuting at the AMP Annual Meeting. The collaboration expands Clear Labs' automation technology into oncology, enabling streamlined, end-to-end NGS workflows for...Clear Labs Launches Clear Dx™ Deeplex® Myc-TB, An Automated Solution for Mycobacterium Species Identification and TB Drug Resistance Mutations
Clear Labs and GenoScreen introduce Clear Dx™ Deeplex® Myc-TB, an automated next-day solution for rapid TB and NTM identification with drug resistance insights. SAN CARLOS, Calif., Aug. 26, 2025 /PRNewswire-PRWeb/ -- Clear Labs, a leader in automated genomic sequencing solutions, is proud...Clear Labs Launches New Fully Automated NGS Platform for Rapid Bacterial and Fungal Detection from Sterile Site Specimens
Clear Labs introduces an automated NGS assay that identifies bacteria and fungi from sterile site specimens with next-day results and minimal hands-on time. SAN CARLOS, Calif., June 4, 2025 /PRNewswire-PRWeb/ -- Clear Labs, a leader in fully automated next-generation sequencing (NGS)...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Clear Labs
Sign Up For FreeTo access detailed company insights
Clear Labs, Inc. is a private genomics testing company headquartered in San Carlos, California, United States. It offers a fully automated, next-generation sequencing (NGS) platform for turnkey diagnostics, including SARS-CoV-2 genomic characterization and detection of foodborne pathogens such as listeria and salmonella. Clear Labs was co-founded b... Read More
